Funding & Partnerships AIM-HI Accelerator Fund is a nonprofit that invests in oncology startups and engages in partnerships with investors and biopharma entities, presenting direct access points for potential collaboration, co-investment, and sponsored programs.

Women Entrepreneurs They run Women’s Venture initiatives and have semi-finalists milestones, indicating a focus on supporting women scientist-entrepreneurs—opportunity for targeted outreach, mentorship programs, accelerators, and grant partnerships.

Global Engagement Active international portfolio moves, such as DotBio’s pre-Series A investment, suggest AIM-HI has a global network; leverage for cross-border partnerships, technology licensing, and market-entry collaborations in Asia-Pacific and beyond.

Clinical Translation Their mission centers on moving discoveries from lab to clinic, signaling interest in translational services, regulatory strategy, clinical trial operations support, and patient-access pathways as value offerings.

Thought Leadership Leadership awards and industry recognition indicate openness to collaboration with academic and industry thought leaders; potential for sponsored research programs, conference partnerships, and joint initiatives to elevate cancer innovation.